Thermo Fisher Scientific, and Arsenal Biosciences, Inc., a clinical-stage cell therapy company engineering advanced chimeric antigen receptor (CAR)-T cell therapies for solid tumors, have updated their strategic collaboration to further the development of manufacturing processes for new cancer treatments. The research and process development-focused collaboration has enabled ArsenalBio to develop a robust manufacturing process for their next-generation, programmable autologous T cells for the...